Registered Uganda · NDA

DOLUTEGRAVIR SODIUM + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE

NDA/MAL/HDP/8814 ORAL SOLID ORDINARY FILM-COATED TABLETS 50MG + 300MG + 300MG

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
NDA/MAL/HDP/8814
Registration date
30/05/2018
Expiry date
-
Status
Registered
Active ingredient
-
Strength
50MG + 300MG + 300MG
Pack size
1.0X1.0X30.0 TABLET BOTTLE,1.0X90.0 TABLET BOTTLE,1.0X180.0 TABLET BOTTLE
Therapeutic class
-
Manufacturer / MAH
Mylan Laboratories Limitedd
Applicant / LTR
MYLAN LABORATORIES LIMITED
Country of origin
INDIA
Manufacturer location
JJM9+39P, Pithampur Industrial Area, Kalibillod, Madhya Pradesh 454774, India

Source: National Drug Authority · fetched 2026-04-21 17:37:10 · updated 2026-09-12 04:00:21

Disclaimer: This information is sourced from National Drug Authority (Uganda). Always consult a qualified healthcare professional before using any medication.